Acro-Renal Mandibular Syndrome (ARMS)

Acro-renal-mandibular syndrome is a very rare condition that is present from birth. It affects three main body areas at the same time: the hands and feet (“acro”), the kidneys and urinary system (“renal”), and the lower jaw (“mandibular”). Babies or children may have split hand or split foot differences (missing or separated middle fingers or toes), kidney changes (one kidney missing, small or in the wrong place, or tube blockages), and a small or under-developed lower jaw. These changes happen during early pregnancy when the limbs, kidneys, and face are forming at similar times. Reports suggest the condition can run in families, sometimes in an autosomal recessive pattern (both parents carry a silent gene change), and it has been described in siblings born to related parents (consanguinity). Because ARMS is rare, we do not yet have one single proven gene that explains all cases; some people with “split hand/foot” patterns have changes in genes like TP63, but ARMS itself may not always be linked to TP63. PubMedNational Organization for Rare DisordersOrphaOxford Academic+1

Acro-renal-mandibular syndrome is a very rare condition that starts before birth. It mainly affects three body areas: the hands and feet (“acro”), the kidneys (“renal”), and the lower jaw (“mandibular”). Children may be born with missing or split fingers or toes, kidney problems like absent or small kidneys, and a small lower jaw. Many babies are diagnosed during pregnancy because the ultrasound shows limb changes and kidney problems. Scientists think it is usually inherited in an autosomal recessive way, which means both parents silently carry one copy of the changed gene, but the exact gene has not been proven yet. Because the kidneys may be severely affected, some babies become very sick right after birth. OrphaNational Organization for Rare DisordersPubMed

Other names

Doctors and researchers have used several names for this same pattern:

1. Acrorenal-mandibular syndrome (ARM syndrome).

2. Acro-renal-uterine-mandibular syndrome (ARUMS) when female reproductive organs are also affected.

3. Split-hand/split-foot syndrome with mandibular hypoplasia (because the classic limb change is a “split” hand or foot and the jaw is small).

4. Acrorenal syndrome, mandibular variant (a descriptive label used in some reports).

These names describe the same rare group of findings that involve the limbs, kidneys, and jaw, sometimes with uterine changes in girls or women. PMCLippincott Journals

Types

There is no single official “type” list in textbooks, because the condition is very rare. But doctors often sort cases by what organs are most affected. This helps with care and planning.

Type 1: Classic ARM pattern.
This type shows split hands and/or split feet (also called ectrodactyly), kidney problems (like small kidneys or blocked urine flow), and a small lower jaw. The palate may be high or cleft. Babies are usually noticed before birth on ultrasound. OrphaPMC

Type 2: ARM with severe kidney failure (lethal renal form).
Some babies have both kidneys absent or barely developed. This can lead to very low amniotic fluid, small lungs, and serious breathing problems after delivery. Sadly, this form is often fatal. PMC

Type 3: ARUMS (ARM plus uterine anomalies).
Girls may also have uterine differences such as bicornuate, septate, or unicornuate uterus. Joint dislocations and hydronephrosis have also been reported in this pattern. Lippincott Journals

Type 4: ARM with atypical limb pattern.
A few reports describe extra digits (polydactyly) instead of split hands/feet, or different bone changes in arms and legs, but still with kidney and jaw involvement. Banglajol

Type 5: Mild mandibular involvement.
In rare families, limb and renal findings are present while the jaw is near normal, or the jaw problem is limited to a high-arched palate or mild micrognathia. PubMed

Causes

Important note: because this syndrome is extremely rare, one single proven gene cause is not yet established. The items below explain what researchers think are likely reasons or contributing factors based on case reports and on what we know about limb and kidney development in general.

1. Autosomal recessive inheritance.
   Most families with more than one affected child show a recessive pattern. This means both parents are healthy carriers. PubMed

2. Parental consanguinity (parents related by blood).
   Some reported families involved close relatives as parents, which increases the chance both parents carry the same rare gene change. PubMed

3. Abnormal epithelial–mesenchymal signaling during early development.
   The limbs and kidneys both need tight “cross-talk” between tissues. Disruption can produce split hands/feet and kidney malformations together. PMC

4. Failure of the ureteric bud–metanephric mesenchyme interaction.
   This is a key step for kidneys to grow. If it fails, kidneys can be absent or small. JCI

5. Disturbed apical ectodermal ridge (AER) function in the limb bud.
   The AER guides finger and toe formation. Problems here can cause split hands/feet. (This is a general limb-development principle used to explain the limb part.) Cell

6. Disruption of HOX signaling networks.
   HOX genes help pattern limbs and also contribute to kidney development; broad disturbance could affect both systems. (This is a biologic mechanism suggested by limb–renal research, not a proven ARM gene.) PLOS

7. SALL family gene pathway disturbance (conceptual mechanism).
   SALL1 is critical for kidney formation and also linked to limb anomalies in other syndromes; ARM may involve related pathways even if SALL1 itself is not proven here. PubMedPMC

8. Shared “acro-renal” developmental field vulnerability.
   Reviews show limb and urinary tract defects often occur together, suggesting a common developmental field that can be upset by various genetic hits. PMC

9. Maternal diabetes as a background risk for CAKUT.
   Maternal diabetes increases risk for kidney/urinary tract anomalies in general; in a fetus predisposed to ARM, this could worsen the renal picture. (Population-level CAKUT data.) Frontiers

10. Maternal obesity and other maternal chronic diseases (background CAKUT risks).
    These conditions raise CAKUT risk overall; they are not specific to ARM but may add risk to kidney malformations in any fetus. Frontiers

11. Gene–environment interactions.
    A baby with a sensitive developmental pathway may show stronger defects when combined with environmental insults. This is a general concept supported in kidney-development literature. JCI

12. Early vascular disruption in the limb.
    Loss of blood flow can cause split hand/foot patterns in general; this is a theoretical limb mechanism for some cases. Cell

13. Chromosomal microdeletions or duplications (rare, non-specific).
    While no consistent chromosomal change defines ARM, genome-wide testing can sometimes reveal copy-number changes that affect limb-kidney pathways. (General CAKUT/genetics practice.) Frontiers

14. Disturbed SHH–FGF feedback loop in limb buds.
    This loop controls digit formation; broader pathway changes also relate to urinary tract development in other conditions. Frontiers

15. Defects in extracellular matrix or cell migration during organ shaping.
    Both limb rays and kidney collecting ducts require precise cell movement and matrix signals. General developmental reviews support this mechanism. JCI

16. Maternal exposure to certain drugs or teratogens in early pregnancy (non-specific).
    Some exposures raise CAKUT risk broadly; they are not proven ARM causes but can add risk. Frontiers

17. Epigenetic changes affecting early organ patterning.
    Epigenetic influences are recognized in CAKUT; they may modify severity in ARM. Frontiers

18. Male or female sex-specific modifiers (uterine changes in females).
    Girls can show uterine anomalies along with limb–renal findings (ARUMS), suggesting sex-specific developmental modifiers. Lippincott Journals

19. Family-specific private variants.
    Because ARM is so rare, some families may have unique rare variants in limb–kidney regulators that current tests cannot easily label. (General inference from CAKUT/acro-renal reviews.) PMC

20. Unknown or unidentifiable causes.
    In many cases, today’s genetic tests still cannot find a single cause, even when the clinical diagnosis is clear. Orpha

Symptoms and signs

1. Unusual hands or feet at birth.
   Fingers or toes may be split (cleft hand/foot) or missing; sometimes there are extra digits. This is often the first visible sign. PMCBanglajol

2. Very small lower jaw (micrognathia).
   The chin looks small, and the baby may have feeding or breathing difficulty because the tongue falls back. AccessPediatrics

3. High-arched or cleft palate.
   The roof of the mouth may be very high or not fully closed, which can affect feeding and speech later. AccessPediatrics

4. Low or no urine after birth.
   If kidneys are very small or absent, the baby may pass little or no urine and may develop swelling and chemical imbalances. Orpha

5. Breathing trouble in the newborn period.
   Severe kidney problems can cause very low amniotic fluid before birth, leading to small lungs (pulmonary hypoplasia) and breathing problems. PMC

6. Recurrent urinary infections in infancy or childhood.
   If urine flow is abnormal, infections can occur again and again. JCI

7. Poor growth and feeding problems.
   Jaw and palate issues make feeding hard; kidney disease also reduces appetite and growth. AccessPediatrics

8. Joint stiffness or dislocations.
   Some babies have joint contractures or dislocations (for example, the knee), which affect movement. Lippincott Journals

9. Spine or rib differences.
   Vertebral or rib anomalies may be present and can be seen on X-rays. PMC

10. Chest shape differences.
    Some children show chest wall differences like pectus carinatum. Wikipedia

11. Ear shape and position differences.
    Ears may sit low or appear rotated; hearing may be affected in some cases. AccessPediatrics

12. Face differences beyond the jaw.
    There may be a short neck or under-developed cheekbone (zygoma). Wikipedia

13. Hip problems.
    Hips can be unstable or dislocated, which shows up on exam. Wikipedia

14. Female reproductive tract differences.
    Girls can have a bicornuate, septate, or unicornuate uterus, which may affect periods and pregnancy later in life. Lippincott Journals

15. Before birth: low amniotic fluid and slow growth.
    Pregnancy ultrasound may show oligohydramnios and intrauterine growth restriction. Wikipedia

Diagnostic tests

A) Physical examination (bedside checks)

1. Full newborn exam.
   The doctor looks carefully at hands, feet, jaw, palate, ears, chest, spine, and genitals to map all findings. This guides the rest of the testing. PMC

2. Airway and feeding assessment.
   Micrognathia and cleft palate can make breathing and feeding hard; early bedside checks direct urgent support. AccessPediatrics

3. Blood pressure measurement.
   High blood pressure can appear with kidney disease, even in children; checking early gives a baseline. JCI

4. Growth and nutrition review.
   Weight, length, and head size are tracked often, because kidney disease and feeding problems affect growth. JCI

5. Joint, hip, and spine exam.
   The clinician checks for contractures, dislocations, clubfoot, and spine differences that need orthopedic care. Lippincott Journals

B) Manual tests (hands-on maneuvers done by the examiner)

6. Barlow and Ortolani maneuvers for hip stability.
   These gentle maneuvers check if the hip is dislocated or unstable in the newborn. (Useful because hip problems can co-occur.) Wikipedia

7. Passive range-of-motion testing of joints.
   The examiner moves the baby’s joints to feel stiffness or contractures that need therapy. PMC

8. Airway positioning and jaw-thrust responsiveness.
   Bedside airway tests help decide if immediate support or a special feeding plan is needed in micrognathia/cleft palate. AccessPediatrics

9. Clubfoot assessment (Ponseti readiness).
   Hands-on foot evaluation helps plan early casting if needed for mobility. PMC

10. Functional hand tests (age-appropriate).
    As the child grows, therapists check grasp, pinch, and reach to plan splints or surgery for split-hand/split-foot. PMC

C) Laboratory and pathological tests

11. Serum creatinine and blood urea nitrogen (BUN).
    These blood tests show how well the kidneys filter waste. They are checked soon after birth and monitored over time. JCI

12. Electrolytes and acid–base panel.
    Sodium, potassium, bicarbonate, and others help detect kidney-related imbalances that may need urgent correction. JCI

13. Urinalysis and urine culture.
    These tests look for protein, blood, and infection, which are common when the urinary tract is abnormal. JCI

14. Newborn screening plus targeted metabolic tests when indicated.
    These help rule out other rare disorders that can mimic parts of the picture. (General pediatric practice.) JCI

15. Chromosomal microarray (CMA).
    A genome-wide test that can find missing or extra DNA sections (copy-number changes) that sometimes explain limb–renal syndromes. Even if negative, it is still useful to try. Frontiers

16. Exome or genome sequencing (singleton or trio).
    When CMA is negative, sequencing can look for rare variants in genes that guide limb and kidney development. A result may direct care and family counseling even if ARM has no single known gene. Frontiers

17. Renal function trend labs (albumin, calcium/phosphate, PTH).
    These help track chronic kidney disease effects on bones and nutrition. JCI

18. Pregnancy labs (maternal).
    Maternal diabetes and certain conditions increase CAKUT risk; checking maternal health helps with counseling in future pregnancies. Frontiers

D) Electrodiagnostic and physiologic tests

19. Automated auditory brainstem response (AABR) or ABR.
    This is a gentle electrical test to check hearing in newborns. Some cases have ear differences, so screening is helpful. AccessPediatrics

20. Urodynamic study with sphincter EMG (when older).
    If urinary control is abnormal, this test measures bladder pressure and muscle activity to guide treatment. (Used in broader CAKUT care.) JCI

21. Polysomnography (sleep study) if airway obstruction is suspected.
    Micrognathia and cleft palate can cause obstructive sleep apnea; a sleep study measures breathing and oxygen during sleep. AccessPediatrics

22. Electrocardiogram (ECG) when surgery or anesthesia is planned.
    This is routine safety testing; some children with complex syndromes also have heart differences that should be checked. (General pediatric pre-op practice.) Wiley Online Library

E) Imaging tests

23. Prenatal ultrasound.
    This is usually the first test that finds ARM. It can show limb differences, kidney agenesis/hypoplasia, and low amniotic fluid. Orpha

24. Fetal MRI (selected cases).
    MRI can help when ultrasound needs more detail about the jaw, chest, kidneys, or other organs before delivery. Frontiers

25. Postnatal renal and bladder ultrasound.
    This is the key first imaging test after birth to confirm the size and structure of the kidneys and urinary tract. JCI

26. Voiding cystourethrogram (VCUG).
    This X-ray test looks for backward flow of urine (reflux) or blockages at the bladder outlet, which are common in abnormal urinary tracts. JCI

27. X-rays of limbs and jaw.
    Plain films show which bones are missing or split and help surgeons plan treatment. PMC

28. 3-D CT of the face and mandible (selected cases).
    When jaw surgery is considered, 3-D imaging helps measure bone size and airway space. AccessPediatrics

29. Spine and chest imaging.
    If there is concern for rib, vertebral, or lung under-development, imaging helps plan breathing support and therapy. PMC

30. Echocardiogram when indicated.
    An ultrasound of the heart checks for heart differences that sometimes accompany multiple-anomaly syndromes. (General syndromic work-up.) Wiley Online Library

Non-pharmacological treatments

(15 physiotherapy/rehab items are included; the rest cover mind-body care, education, assistive tech, nutrition, and research/ethics. Each item lists description → purpose → mechanism → benefits.)

1. Early physiotherapy assessment → Evaluate muscle tone, joint range, and functional grasp/gait. → Sets baseline and goals. → Guides a safe, tailored plan; prevents stiffness.

2. Range-of-motion (ROM) exercises → Gentle daily movements for wrists, elbows, ankles, and toes. → Keeps capsules/ligaments mobile. → Less contracture, better reach and walking.

3. Strengthening for proximal muscles → Core/shoulder/hip work with play-based tasks. → Compensates for distal differences. → Improves balance, transfers, and endurance.

4. Gait training and orthotics → Custom insoles/ankle-foot orthoses; practice energy-efficient gait. → Realigns foot loading. → Fewer falls; less pain and fatigue.

5. Prosthetics and adaptive devices → Partial hand/foot prostheses, activity-specific tools. → Restores pinch, grip, and push-off. → Better independence in school/play.

6. Occupational therapy for hand function → Task-specific training, adaptive grips, switch access. → Motor learning and neuroplasticity. → Faster self-care (feeding, dressing, writing).

7. Constraint-induced bimanual therapy (when appropriate) → Intensive practice of the affected limb. → Rewires cortical use patterns. → Better dexterity and confidence.

8. Splinting/serial casting → Night splints or short casting series for deformity prevention. → Low-load prolonged stretch. → Maintains alignment; easier shoe wear.

9. Hydrotherapy (aquatic therapy) → Movement in water to reduce joint load. → Buoyancy + resistance. → Safe strengthening; improved endurance.

10. Respiratory/airway positioning in micrognathia → Side/prone positioning, nasopharyngeal airway as advised. → Opens airway pathway. → Safer feeding and sleep pending surgical decisions. Pediatrics

11. Feeding and swallowing therapy → Pacing, nipple choices, thickened feeds if indicated. → Protects airway; improves nutrition. → Better weight gain and fewer choking episodes.

12. Speech-language therapy → Addresses articulation (palate/jaw), resonance, and language. → Motor speech training. → Clearer speech and social participation.

13. Toilet/bladder training with urotherapy → Timed voiding, hydration, constipation control. → Optimizes bladder emptying. → Fewer UTIs and less reflux risk. Pediatrics

14. Kidney-protective lifestyle coaching → Hydration targets, nephrotoxin avoidance (NSAIDs without doctor advice), sick-day plans. → Lowers kidney stress. → Slower CKD progression. KDIGO

15. Nutritional counseling (pediatric renal dietitian) → Energy/protein adequacy; sodium and phosphate awareness. → Matches diet to labs and growth. → Better growth and CKD-MBD control. KDIGO

Mind-body & educational / supportive

16. Family-centered education → Simple teaching on ARMS, kidney care, and signs to watch. → Health literacy. → Earlier help-seeking; safer home care.

17. Psychological support → Coping skills for child and caregivers. → Stress reduction, adherence support. → Lower anxiety; better therapy follow-through.

18. School IEP/504 planning → Seating, handwriting alternatives, extra time, restroom access. → Removes learning barriers. → Better academic progress and inclusion.

19. Peer support/community groups → Connect with families facing limb/kidney differences. → Social modeling and shared tips. → Reduced isolation; practical solutions.

20. Protective footwear & home safety → Shock-absorbing shoes, non-slip surfaces. → Reduces falls and skin breakdown. → Keeps kids active safely.

21. Oral health program → Fluoride, regular dental follow-up (jaw/palate issues). → Prevents caries/infections. → Fewer dental emergencies.

22. Vaccination review (especially if CKD) → Keep routine immunizations current, including influenza/hepatitis B per guidance. → Infection prevention. → Fewer hospitalizations. KDIGO

23. Genetic counseling → Inheritance patterns, recurrence risks, prenatal options. → Informed decisions. → Supports future family planning. Genetic Rare Diseases Center

24. Clinical registry/enrollment in natural-history or rehabilitation studies → Track progress; improve evidence for ARMS. → Data-driven care. → Access to resources, earlier innovations.

25. Research awareness: gene/cell therapy is experimental → Discuss trial opportunities only via regulated studies; not standard care for ARMS today. → Safety and ethics first. → Avoids unproven or risky interventions. PMCLippincott Journals

---

Drug treatments

Medicines in ARMS target kidney health, blood pressure, bone-mineral balance, anemia, growth, pain, and infections. Always dose by weight/age, kidney function, and local guidelines.

1. ACE inhibitor (e.g., enalapril)
   Purpose: control blood pressure and reduce protein in urine.
   Mechanism: blocks renin–angiotensin system (vasodilation; ↓intraglomerular pressure).
   Typical pediatric start: ~0.08 mg/kg once daily (max usually 40 mg/day); titrate to targets.
   Key cautions: cough, high potassium, creatinine rise; avoid ACEi+ARB+DRI combinations. Drugs.comKDIGO+1

2. ARB (e.g., losartan)
   Purpose: alternative to ACEi or if cough occurs.
   Mechanism: blocks angiotensin II receptor.
   Typical pediatric start: ~0.7 mg/kg/day (up to 50 mg), titrate; higher doses up to 1.4 mg/kg studied.
   Side effects: dizziness, high potassium, kidney function changes. Mayo ClinicDrugs.comPMC

3. Calcium-channel blocker (e.g., amlodipine)
   Purpose: additional BP control.
   Mechanism: arterial vasodilation.
   Dosing: studies report ~0.1–0.4 mg/kg/day (age-dependent needs); monitor edema. PubMedWiley Online Library

4. Loop diuretic (e.g., furosemide)
   Purpose: edema or difficult BP control with volume overload.
   Mechanism: blocks Na-K-2Cl in loop of Henle → diuresis.
   Pediatric dosing examples: ~1–2 mg/kg/dose (max per dose often 6 mg/kg) with interval per response.
   Risks: dehydration, low K/Na, ototoxicity at high IV doses. Drugs.comMedscape Reference

5. Erythropoiesis-stimulating agent (epoetin alfa)
   Purpose: CKD anemia when Hb <10 g/dL after iron repletion.
   Mechanism: stimulates RBC production.
   Typical pediatric start: 50 U/kg 3×/week IV/SC; adjust to avoid Hb >12.
   Risks: hypertension, thrombosis (follow protocols). NCBIamgenesas.com

6. Oral iron (elemental iron)
   Purpose: treat iron deficiency in CKD anemia or due to frequent labs/infections.
   Mechanism: supplies iron for hemoglobin.
   Dosing: individualized by ferritin/TSAT; watch constipation and tooth staining; use with vitamin C for absorption (per clinician).

7. Active vitamin D (calcitriol)
   Purpose: CKD-MBD (low calcium/high PTH).
   Mechanism: active vitamin D receptor agonist → ↑Ca absorption, ↓PTH.
   Pediatric dosing varies by age and labs (e.g., 0.25 mcg daily then titrate; dialysis regimens differ).
   Risks: high calcium/phosphate; needs frequent labs. Medscape ReferenceDrugs.com

8. Phosphate binders (e.g., sevelamer)
   Purpose: lower high phosphate in CKD-MBD.
   Mechanism: binds dietary phosphate in gut.
   Dosing: with meals; titrate to serum phosphate; watch GI upset.

9. Sodium bicarbonate or citrate
   Purpose: correct chronic metabolic acidosis in CKD.
   Mechanism: provides base to raise serum bicarbonate.
   Dosing is individualized; clinicians often aim to normalize serum HCO₃⁻; options include tablets/solutions.
   Cautions: sodium load, fluid retention; citrate interacts with aluminum. PMCNCBI

10. Antibiotics for UTIs (culture-guided; prophylaxis in select cases)
    Purpose: treat or prevent kidney infections in children at higher risk (reflux, obstruction, bladder dysfunction).
    Mechanism: eradicates bacteria.
    Use: shortest effective course; avoid overuse; follow pediatric UTI guidance. Pediatrics

11. Analgesics (acetaminophen first-line)
    Purpose: pain from surgeries/orthotics.
    Mechanism: central COX effects; renal-safer than NSAIDs.
    Caution: avoid routine NSAIDs without nephrology guidance.

12. Antihypertensive add-ons
    Purpose: reach ABPM targets (often ≤50th percentile MAP in CKD).
    Examples: beta-blockers, additional CCBs as needed. KDIGO

13. Vitamin D3 (cholecalciferol) maintenance
    Purpose: maintain adequate 25-OH-D along with calcitriol strategy.
    Mechanism: substrate for active vitamin D.
    Dosing: per labs and local pediatric CKD guidance.

14. Bowel regimen (polyethylene glycol, fiber)
    Purpose: prevent constipation to lower UTI risk in bladder–bowel dysfunction.
    Mechanism: stool softening/bulking.
    Benefit: fewer infections and better toileting.

15. Recombinant human growth hormone (rhGH)
    Purpose: persistent growth failure in CKD after nutrition optimization.
    Mechanism: promotes linear growth.
    Use: in stage 3–5 CKD or dialysis with defined criteria; dosing and monitoring per pediatric endocrinology/nephrology. PubMedNature

---

Dietary “molecular” supplements

1. Vitamin D3 → Maintain repletion; supports bone health with CKD-MBD care. Mechanism: raises 25-OH-D (substrate). KDIGO

2. Active vitamin D (calcitriol) → See above; for high PTH/low Ca. Mechanism: VDR agonist. Medscape Reference

3. Elemental iron → Improves iron deficiency anemia; builds hemoglobin.

4. Omega-3 fatty acids → May modestly aid BP/inflammation; evidence variable in CKD—use case-by-case.

5. B-complex (including folate) → Supports RBC production and appetite; avoid megadoses without advice.

6. Probiotics → Investigational for lowering uremic toxins; consider only with clinician oversight.

7. Citrate solution (as alkali source) → Alternative to tablets if bicarbonate not tolerated. PMC

8. Calcium (dietary, not excess supplements) → Only per nephrology to avoid hypercalcemia/phosphate issues.

9. Phosphate binders with meals → Technically medications; listed here to emphasize meal-timing importance.

10. Oral nutritional supplements → High-calorie formulas to support growth if intake is low.

---

Regenerative / stem-cell drugs

There are no approved “immunity-booster,” stem-cell, or gene-therapy drugs for ARMS. Cell and gene therapies for kidney disease and skeletal repair are experimental and should only be accessed in regulated clinical trials after careful risk–benefit discussion. Below are research areas, not standard treatments:

1. Mesenchymal stem cells (MSC) for CKD—clinical trials
   Investigated for immune modulation and anti-fibrotic effects; early trials focus on safety and signals, not cures. PMCClinicalTrials.gov

2. Renal autologous cell therapy (e.g., investigational products such as rilparencel)
   Autologous renal cell injections are under study for diabetic CKD; not approved for children with ARMS. Wall Street Journal

3. Extracellular vesicles (EVs) from MSCs—preclinical/early clinical research
   Aim to deliver paracrine signals without live cells. Wiley Online Library

4. Localized gene-therapy strategies for bone repair (research stage)
   Regional gene delivery (e.g., BMP-related) explored for segmental defects; not an ARMS therapy today. PMCMDPI

5. AAV-based gene therapy platforms (various diseases)
   Show success in some genetic disorders, but no proven indication for ARMS. Nature

6. Immune health optimization (vaccinations, nutrition, sleep)
   Evidence-based “immune support” relies on vaccines and general health, not booster drugs. (See prevention section.) KDIGO

---

Surgeries

1. Cleft hand/foot reconstruction
   Procedure: central cleft closure, tendon balancing, syndactyly release; individualized by deformity (e.g., Snow-Littler techniques).
   Why: improve pinch, grasp, and shoe fit; reduce skin problems. Lippincott JournalsPMC

2. Pollicization or thumb reconstruction (select cases)
   Procedure: create/move a digit to function as a thumb.
   Why: restore opposition and fine motor function. SAGE Journals

3. Mandibular distraction osteogenesis (MDO)
   Procedure: gradually lengthen the small lower jaw with distraction devices.
   Why: open the airway, improve feeding, reduce need for tracheostomy in symptomatic micrognathia. PediatricsPubMed

4. Pyeloplasty for UPJ obstruction
   Procedure: remove the narrowed segment and reattach the ureter (open, laparoscopic, or robot-assisted).
   Why: relieve obstruction, protect kidney function—especially crucial with solitary/abnormal kidneys. PMC+1

5. Kidney transplantation (if ESRD develops)
   Procedure: transplant a healthy donor kidney.
   Why: restore kidney function when medical/surgical options are no longer enough. (Standard CKD care pathway per pediatric nephrology guidelines.) KDIGO

---

Preventions

1. Regular nephrology and urology follow-up with blood/urine tests and ultrasound schedules. PMC

2. Blood-pressure monitoring at home/clinic; follow CKD pediatric targets (often ≤50th percentile MAP on ABPM). KDIGO

3. UTI prevention: hydration, timed voiding, constipation control, correct wiping, and quick care for fever. Pediatrics

4. Avoid nephrotoxins without specialist advice (NSAIDs, certain contrast dyes, some herbal products). KDIGO

5. Vaccinations up to date (including influenza/hep B as indicated in CKD). KDIGO

6. Growth and nutrition tracking with a renal dietitian. KDIGO

7. Dental/oral health program to lower infection risk and support speech/feeding.

8. Safe activity plan with orthotics/shoes to prevent falls or skin breakdown.

9. Written “sick-day” plan (what to hold, when to call). KDIGO

10. Genetic counseling for family planning and prenatal options. Genetic Rare Diseases Center

---

When to see doctors urgently

• Breathing difficulty, noisy breathing, bluish lips, or trouble feeding in infants with small jaw. Pediatrics

• Fever, vomiting, pain with urination, or foul urine (possible UTI). Pediatrics

• Very swollen legs/face, sudden weight gain, very low or no urine, or high blood pressure readings. KDIGO

• Poor weight gain, extreme tiredness, or paleness (possible anemia). KDIGO

• Skin breakdown or painful pressure areas from orthotics or prosthetics.

---

What to eat” and “what to avoid”

Eat more of:

1. Fresh fruits/vegetables in amounts that fit potassium labs (dietitian will tailor choices).

2. Lean proteins (eggs, chicken, fish) in amounts matched to growth and kidney stage.

3. Whole grains and healthy fats (olive/canola oil) for energy.

4. Adequate calcium and vitamin D sources per the care plan. KDIGO

5. High-calorie smoothies or renal-friendly formulas if weight gain is slow (dietitian-guided).

Limit/avoid:

1. Added salt/salty snacks (chips, instant noodles, pickles). BP and fluid control matter. KDIGO
2. High-phosphate processed foods (processed meats, cola, processed cheese) if phosphate is high. KDIGO
3. Very high-potassium foods only if labs show hyperkalemia (e.g., large banana/avocado portions)—swap with lower-K options per dietitian.
4. Sugar-sweetened drinks—choose water; supports bladder health and weight.
5. Herbal/over-the-counter products without nephrology approval (some harm kidneys). KDIGO

---

Frequently Asked Questions (FAQs)

1) Is ARMS the same as “acro-renal” or “acro-renal-ocular” syndrome?
They overlap. ARMS includes limb + kidney + jaw features; “acro-renal-ocular” adds eye findings. Doctors use exams, imaging, and genetics to define your child’s exact pattern. Orpha

2) What causes ARMS?
It’s genetic in origin, but the exact gene is not always known. Some “split hand/foot” patterns relate to genes such as TP63, but ARMS itself may not always be linked to one known gene. Oxford AcademicPubMed

3) How is ARMS diagnosed?
By physical exam (hands/feet/jaw), kidney imaging (ultrasound; sometimes MAG-3 scan or MRI), and targeted genetics; your team may add heart, hearing, and eye checks based on findings. PMC

4) Will my child need surgery?
Sometimes—e.g., hand/foot reconstruction for function, MDO for airway/feeding, or pyeloplasty for kidney drainage. Timing is individualized. PediatricsPMC

5) Can ARMS be “cured”?
There’s no single cure; care focuses on function, growth, kidney protection, and quality of life. Research on gene/cell therapies is ongoing but not standard. PMC

6) What is the outlook for the kidneys?
It varies—from normal function to chronic kidney disease. Regular follow-up, BP control, UTI prevention, and surgery when needed help protect function. KDIGO

7) Why is blood pressure control so important?
High BP speeds kidney damage. In children with CKD, guidelines suggest ABPM targets around the 50th percentile MAP. KDIGO

8) Are ACE inhibitors safe for kids?
They are widely used with careful labs to watch potassium and creatinine, and they should not be combined with ARBs/DRIs. KDIGO

9) What about growth?
Nutrition comes first. If growth failure persists, rhGH may be offered under specialist protocols. PubMed

10) How can we prevent UTIs?
Hydration, timed voiding, bowel management, and early treatment when fever/urinary symptoms occur. Pediatrics

11) Will my child need a transplant?
Only if kidney failure progresses to end-stage disease; many children never need it. KDIGO

12) Is pregnancy possible later in life?
Many people with limb differences can have healthy pregnancies. Kidney status, blood pressure, and any pelvic/uterine anomalies will guide counseling.

13) Can ARMS affect learning?
Intelligence is usually normal. Occupational/speech therapy and school accommodations remove barriers to participation.

14) Should our family get genetic counseling?
Yes—counseling explains inheritance and future risks, and reviews testing options. Genetic Rare Diseases Center

15) Where can we find reliable information?
Trusted summaries: Orphanet, GARD, and peer-reviewed case reports/reviews on acro-renal conditions. OrphaGenetic Rare Diseases Center

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 02, 2025.